5-FU, 5-fluorouracil; AD, Alzheimer's disease; AMCNS, cationic niosome-based azithromycin delivery systems; AP, acetylpuerarin; AT1R, angiotensin II receptor type 1; AmB, amphotericin B; BCRP, breast cancer resistance protein; CNL, conventional lipid nanoparticles; CSC, core shell corona nanolipoparticles; DCK, N-deoxycholyl-l-lysyl-methylester; DDS, drug delivery system; DM, diabetes mellitus; DOX, doxorubicin; Drug delivery system; EPR, enhanced permeability and retention effect; FRET, Foster resonance energy transfer; GI, gastrointestinal; GMO, glyceryl monoolein; IBD, inflammatory bowel disease; LG, Lakshadi Guggul; LNC, Lipid Nanocapsule; MFS, Miltefosine; MNBNC, Micronucleated Binucleated Cells; MSN, mesoporous silica nanoparticle; MTX, methotrexate; NP, nanoparticle; NPC, nanoparticulate carriers; NSAID, non-steroidal anti-inflammatory drug; Nanostructures; OA, osteoarthritis; OXA, oxaliplatin; Oral medicine; PAMAM, poly (amidoamine); PD, Parkinson's disease; PEG, polyethylene glycol; PIP, 1-piperoylpiperidine; PLGA, polylactic-co-glycolic acid; PNL, PEGylated lipid nanoparticles; PZQ, praziquantel; SLN, solid lipid nanoparticle; SMA, styrene maleic acid; SMEDD, self microemulsifying drug delivery system; TB, tuberculosis; TNBS, trinitrobenzenesulphonic acid; TPGS, tocopheryl polyethylene glycol succinate; Tmf, tamoxifen; WGA, wheat germ agglutinin; pSi, porous silicon; pSiO, porous silica oxide